{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:12:49Z","timestamp":1724130769330},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.endonu.2010.09.009","type":"journal-article","created":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T09:30:42Z","timestamp":1296293442000},"page":"24-31","source":"Crossref","is-referenced-by-count":4,"title":["Dosis bajas de cinacalcet reducen el calcio s\u00e9rico en pacientes con hiperparatiroidismo primario no subsidiario de tratamiento quir\u00fargico"],"prefix":"10.1016","volume":"58","author":[{"given":"Alfonso","family":"Arranz Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Azc\u00e1rate","family":"Villal\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Luque","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca Santana","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica Marazuela","family":"Azp\u00edroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia Paniagua","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio G\u00f3mez","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2010.09.009_bib0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: Proccedings of the Third International Workshop","volume":"9","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.09.009_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.09.009_bib0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003495-200565020-00007","article-title":"Cinacalcet hydrochloride","volume":"65","author":"Barman Balfour","year":"2005","journal-title":"Drugs."},{"key":"10.1016\/j.endonu.2010.09.009_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003088-200948050-00002","article-title":"Clinical pharmacokinetic and pharamcodynamic profile of cinacalcet hydrochloride","volume":"48","author":"Padhi","year":"2009","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.endonu.2010.09.009_bib0025","unstructured":"EMEA. Mimpara (cinacalcet hydrocholidre). Summary of product characteristics, 2009."},{"key":"10.1016\/j.endonu.2010.09.009_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MAJ.0b013e3181379f3e","article-title":"Acute and One-Year Effects of Cinacalcet in Patients With Persistent Primary Hyperparathyroidism After Unsuccessful Parathyroidectomy","volume":"335","author":"Iglesias","year":"2008","journal-title":"Am J Med Sci."},{"key":"10.1016\/j.endonu.2010.09.009_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1575-0922(09)70843-5","article-title":"Primary hyperparathyroidism. An alternative to the surgery","volume":"56","author":"D\u00edaz Guardiola","year":"2009","journal-title":"Endocrinol Nutr."},{"key":"10.1016\/j.endonu.2010.09.009_bib0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature."},{"key":"10.1016\/j.endonu.2010.09.009_bib0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/jarr.2002.34841","article-title":"Future role of calcimimetics in end-stage renal disease","volume":"9","author":"Goodman","year":"2002","journal-title":"Adv Ren Replace Ther."},{"key":"10.1016\/j.endonu.2010.09.009_bib0050","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism","volume":"63","author":"Moosgaard","year":"2008","journal-title":"Clin Endocrinol."},{"key":"10.1016\/j.endonu.2010.09.009_bib0055","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: Biochemical and bone densitometric outcomes in a five-years study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.09.009_bib0060","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.clinthera.2005.11.015","article-title":"Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism","volume":"27","author":"Dong","year":"2005","journal-title":"Clin Ther."},{"key":"10.1016\/j.endonu.2010.09.009_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000262301","article-title":"Response of secondary hyperparathyroidism to cinacalcet depends on parathyroid size","volume":"114","author":"Hirai","year":"2010","journal-title":"Nephron Clin Pract."},{"key":"10.1016\/j.endonu.2010.09.009_bib0070","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.09.009_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.09.009_bib0080","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J. Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.09.009_bib0085","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1210\/en.2007-0147","article-title":"Constitutive activity of the osteoblast Ca2+-sensig receptor promotes loss of cancellous bone","volume":"148","author":"Dvorak","year":"2007","journal-title":"Endocrinology."},{"key":"10.1016\/j.endonu.2010.09.009_bib0090","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"144","author":"Neer","year":"2001","journal-title":"N Eng J Med."},{"key":"10.1016\/j.endonu.2010.09.009_bib0095","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1210\/jc.85.5.1901","article-title":"Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism","volume":"85","author":"Nakaoka","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.09.009_bib0100","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marocci","year":"2009","journal-title":"J Cin Endocrinol Metab."}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092210002901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092210002901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T05:24:53Z","timestamp":1543987493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092210002901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1575092210002901"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2010.09.009","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}